Connect with us

POZ

PrEP is safe and effective for widespread use, research shows

Worldwide, there are only 300,000 people estimated to be taking PrEP. This is far too small a number to prevent 1.8 million new HIV infections.

Published

on

New research shows that pre-exposure prophylaxis (PrEP) could be given to millions of people worldwide with no increased risk of safety issues during treatment. 

PrEP is a combination of two drugs that people can take before sex to prevent HIV infection. Existing evidence shows that people who take tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) as PrEP have a 90% lower chance of being infected with HIV than people not taking it.

However, widespread use of TDF/FTC can be justified only if its preventative benefits outweigh potential risks of safety issues. These new results, presented today, show that PrEP is safe to use.

The researchers undertook a meta-analysis of 13 randomized trials with 15,678 participants. People at risk of HIV infection were given either TDF/FTC as PrEP or no treatment (the control, or placebo). There was no significant difference in risk of high grade or serious adverse events comparing PrEP with control. The risk of serious adverse events was almost the same for both groups: 9.4% for those on PrEP and 10.1% for those on placebo. There was also no significant difference in risk of renal or bone adverse outcomes. The risk of bone fractures was 3.7% on PrEP versus 3.3% on no treatment. The risk of significant renal dysfunction was 0.1% on PrEP and 0.1% for no treatment.

“In 2016, there were 1.8 million new HIV infections worldwide and the same number again in 2017,” International AIDS Society President Anton Pozniak said. “Across a range of studies, men who have sex with men have one in 30 chance of contracting HIV in a year. Other particularly vulnerable populations’, such as people who inject drugs or sex workers, have a one in 50 chance of being infected with HIV.

READ:  @ItsOfficialNemo: Valuing oneself more while getting a clearer understanding of life

“Worldwide, there are only 300,000 people estimated to be taking PrEP. This is far too small a number to prevent 1.8 million new HIV infections. Clearly, to have a significant effect on the HIV epidemic, we need to scale up PrEP to reach tens of millions of people worldwide.”

Other PrEP modalities, such as long-acting injectable drugs and antibodies, are being tested in order to offer more choices of how PrEP could be taken.

“Globally, there is a new HIV infection every 18 seconds,” study co-author Dr Andrew Hill, from Liverpool University, said. “Every person newly infected will then need to be treated for life, and could transmit HIV to others. We need radical changes in our prevention strategy to cut new HIV infections down to zero.”

The most widely used PrEP, a combination of TDF and FTC, costs only £40 per year to make. A generic TDF/FTC course is available in the UK for £300 per year and £50 in sub-Saharan Africa. With recent legal rulings, low-cost, generic PrEP is becoming more available. This provides an opportunity, with the decreasing costs making it increasingly feasible to provide PrEP to millions of people at risk of HIV worldwide.

“The World Health Organization updated its official guidelines in 2015 to include the use of PrEP as a prevention method,” Dr. Pozniak commented. “The data is clear and it’s time to globally implement this recommendation.”

These results are supported by another recent analysis, which showed no difference in adverse events between TDF/FTC and a combination of tenofovir alafenamide (TAF) and FTC when taken for treatment with an additional antiviral drug.

READ:  The waiting period

NEWSMAKERS

Cebu’s Deaf community taught community-based HIV screening

Select members of the Deaf community from the Province of Cebu were trained on the basics of HIV, and on community-based HIV screening in an effort to “inform them that this issue is just as important to them, and that – given the chance – they can help become the solutions to deal with this.”

Published

on

Helping Deaf Filipinos to help themselves.

Select members of the Deaf community from the Province of Cebu were trained on the basics of HIV, and on community-based HIV screening in an effort to “inform them that this issue is just as important to them, and that – given the chance – they can help become the solutions to deal with this,” said Disney Aguila of Bahaghari Center for Research, Education an Advocacy, Inc. (Bahaghari Center) and Pinoy Deaf Rainbow, Inc.

The training is part of a project by Bahaghari Center, backed by collaboration between Youth LEAD and Y-PEER (Asia Pacific Center), which eyes to address Sexual Reproductive Health and Rights (SRHR)needs of Young Key Populations (YKPs) In Asia and the Pacific.

This project is also a follow-through of the public service announcements (PSAs) developed in Filipino Sign Language (FSL) to specifically tap the Deaf community.

PSA on HIV basics released in Filipino Sign Language

PSA on getting tested for HIV released in Filipino Sign Language

PSA deals in Filipino Sign Language what happens after rapid HIV test

Aguila lamented that “perhaps because the Deaf community is often left behind in HIV-related efforts, we have a lot of catching up to do,” she said.

In Cebu City, for instance, even if participants recognized the importance/urgency of tackling HIV, there are sectors that are still “unable to go beyond their fear of talking about sex and sexuality.”

Noticeably, the Hearing community “may already talk about SOGIE concepts and so on, but – because we have not always been included in discussions, we’re still learning the basics,” Aguila said.

READ:  13 countries from APAC plan scale-up of PrEP and HIV self-testing; challenges remain

This is why, for Aguila, every effort counts to “ensure that we are included in the discussions; and perhaps just as importantly, also empowered so that we need not be dependent on the Hearing community just to be able to access lifesaving services.”

Aguila said that “this development may not come immediately, but every step leading there helps.”

The community-based HIV screening trainings are provided by The Red Ribbon Project, Inc.

Other supporters of the project include: Outrage Magazine, Fringe Publishing, Pinoy Deaf Rainbow, TransDeaf Philippines, Deaf Dykes United and Pinoy Deaf Queer.

Continue Reading

Editor's Picks

Worsening #ARVshortage in the Phl?

On Jan. 9, the Philippines gained a new HIV and AIDS law that is supposed to better the lives of Filipinos living with HIV. But many in the HIV community mark this day with distress, largely because of the worsening ARV shortage.

Published

on

In September 2018, Xander (not his real name; anonymity requested), a Filipino living with HIV, claimed that he was told by the person working in the pharmacy of his hub to “consume already-expired medicines (the three-in-one tablet of Lamivudine/Tenofovir/Efavirenz)”, and that “it is “still good for three months after the expiration date.”

Since dealing with ARV-related issue is not new to him (it happened to him in the last quarter of 2013), he complained and was given newer meds. Noticeably, “those who didn’t complain – like I did – ended up using the expired meds,” he said.

Xander can only recall how he earlier lamented – again in 2013 – that the ARV shortage will happen again, particularly considering the continuing denial of the Department of Health (DOH) about this issue.

TAINTED ‘SUCCESS’

The 9th of January is supposed to be a happy day particularly for Filipinos living with HIV and their advocates. On that day, the newly-signed Republic Act 11166 or the Philippine HIV and AIDS Policy Act was released after it was signed into law by Pres. Rodrigo Roa Duterte. By replacing the 20-year-old Republic Act 8504 or the Philippine National AIDS and Control Act of 1998, this new law is supposed to boost the government’s response to HIV and AIDS by making health services for HIV and AIDS more accessible to Filipinos.

But many in the HIV community mark this day with distress, largely because of the worsening ARV shortage, which is not helped by the denial of the issue by various heads of offices – including government officials, as well as those helming treatment hubs/facilities and even select non-government organizations (NGOs).

In an unsigned statement (as if so that no one can be “chased” to be held accountable for the same statement), the DOH seemed to belittle the issue by outright claiming that there’s an ‘alleged’ shortage of ARVs; even as it also stated that they take the issue of HIV infection in the country seriously. Part of this is to take “great steps to ensure that access for HIV treatments are available for those who are diagnosed with HIV.”

The DOH statement added:
“As of October 2018, we have enrolled 32,224 persons living with HIV for treatment with ARV such as Nevirapine, Lamivudine/Tenofovir. The DOH has been providing free ARV to Filipinos living with HIV through our HIV treatment hubs.
“Based on our records, there are 3,200 registered PLHIV who are on Nevirapine and 1,791 PLHIV on Lamivudine/Tenofovir, as of December last year.

READ:  The waiting period

That just about half of the total PLHIVs in the Philippines use ARVs is worth noting, even if it’s another issue altogether.

But the mention of these two meds/cocktails is important because the complaints reaching – among others – Outrage Magazine, Bahaghari Center for SOGIE Research, Education and Advocacy, Inc. (Bahaghari Center) other and HIV-related community-based organizations/non-government organizations particularly currently mention these.

In Quezon City, for instance, at least eight PLHIVs alleged that they have been given incomplete medications – i.e. they were supplied with either Lamivudine/Tenofovir or Lamivudine/Zidovudine, but they have not been receiving Nevirapine because this is not available. These people are, therefore, taking incomplete meds.

Pinoy Plus’s hotline, PRC, has received similar allegations of non-delivery of Nevirapine.

In Cavite (Imus, Bacoor and Dasmariñas), at least three clients surfaced to allege about the same issue. PLHIVs are now “borrowing” each others’ Nevirapine supply just so they don’t miss their required dosage because their hub does not have supplies from the DOH.

There are similar allegations in Cagayan de Oro City, Davao City and Zamboanga City.

And in Alabang, the pharmacy of a treatment hub even posted on January 8, 2019 an announcement that “due to the shortage and delay of the deliveries at DOH, only one bottle will be dispensed of the following medicines: Nevirapine (200mg tablet); Lamivudine (150mg)/Zidovudine (300mg tablet); and Lamivudine (300mg)/Tenofovir (300mg tablet).” The same hub is telling its clients to “wait for further announcement on stock availability.”

Note that the RITM-AIDS Research Group’s pharmacy is putting the blame on the DOH.

DOH’s CLAIM

The same DOH statement stressed that “the latest data, as of January 4, confirms that Nevirapine has already been delivered to the 16 treatment hubs to meet the requirements for February-April 2019. For Lamivudine/Tenofovir, a month’s supply has also been delivered to Regions X, VI and I. The rest of the regions will expect deliveries within this week.”

READ:  Shola Luna: Pushing forward

Noticeably, the DOH statement responds to issues only this January, even if this concern has been circulating in the PLHIV community since 2018, and only peaked now.

There are fewer ARV refills now. If, in the past, the usual practice is for hubs to give PLHIVs three bottles of ARV to last them for three months, a growing number are now complaining about the supply being cut to one month in numerous hubs – e.g. there’s that post in RITM’s pharmacy. Some allege that they are even supplied ARVs just for a week or even just for three days.

Due to the ARV shortage that the DOH is not outright confronting, expired medicines are allegedly being given to PLHIVs – as in the case of Xander.

Also due to the ARV shortage, the medication of a number of PLHIVs are allegedly being changed not because it’s medically sound, but because their usual medicines are not readily available. In Mandaluyong City, there are PLHIVs who claimed to have been told to use Lamivudine/Tenofovir/Efavirenz because it’s the only available ARV. If they refuse to do so, then they will have to stop taking their usual medications until such time when the delivery of supplies are normalized again.

To allow the DOH to respond to these claims, Outrage Magazine repeatedly reached out to the government body. Upon calling the media relations unit (at +63 2 651-7800 loc. 1126), we were turned over to the office of Dr. Gerard Belimac (+63 2 651-7800 locs. 2355, 2352, 2354). Five attempts were made to speak with Belimac or any other authority in his office, but he has been unavailable at those five times; and even after leaving requests for a statement from him on the ARV shortage, as of press time, the publication has not heard back.

As this is a continuing story, coordination will continue to – eventually hopefully – extensively hear from the DOH on this issue.

WHAT NOW?

The DOH statement also stated that it is “working closely with our suppliers to ensure that there are no gaps in our supply chain. In fact, we are waiting for deliveries of an additional 12,375 bottles of Nevirapine good for another three months and 7,024 bottles of Lamivudine/Tenofovir good for another two months.”

READ:  GLAAD releases new HIV and AIDS style guide for journalists

The DOH also claimed that it is continuing to explore “for more partners in providing excellent support for Filipinos living with HIV-AIDS and in ending the deadly disease.”

As if wanting to pacify the complaining PLHIVs, the DOH statement transferred to responsibility to “HIV doctors to explore possible options”, or visit Facebook page (PLHIV Response Center) or email dohnaspcphiv@gmail.com. Note the use of a gmail account for a body with millions in budget.

No investigations on where the errors in the supply chain is happening so that these can be fixed is forthcoming. No one being held accountable here.

THE NEED TO GO BEYOND LIP SERVICE

Incidentally, Article V, Sec. 33 of the newly signed HIV law states: “The DOH shall establish a program that will provide free and accessible ART and medication for opportunistic infections to all PLHIVs who are enrolled in the program… A manual of procedures for management of PLHIV shall be developed by the DOH.”

The IRR is not even there yet, but this mandate to provide life-saving meds is now already cast in doubt.

Xander – who only had a refill of his ARVs – said that many like him who posted about this issue online were told to stop doing so “because we are supposedly creating panic among PLHIVs.”

He now says that people who cover up this issue are “as worse as those paid to work on this issue. Because if you go to the HIV community, we’ve long lived with worrying that our meds may not be given us at any moment. If some people think complaining about this is wrong, then they shouldn’t be in HIV advocacy, but work as PR people of those failing to do their jobs.”

In the end, “this needs to be resolved fast. Enough with discussing semantics on what we’re having is a shortage or a stockout; the fact remains that there are PLHIVs not getting their supplies. Lives are at stake. So supply the ARVs; now.”

Continue Reading

POZ

HIV and AIDS Policy Act signed into law

The Philippine HIV and AIDS Policy Act updates Republic Act 8504 to incorporate lessons from the current HIV response by introducing “newer evidence-based, human rights-informed, and gender transformative strategies to prevent and treat the epidemic.”

Published

on

The Philippines now has a new law eyeing to strengthen the country’s comprehensive response against HIV and AIDS

People may already be familiar with RA 8504, or the Philippine AIDS Prevention and Control Act of 1998. When it was introduced, RA 11166 or the Philippine HIV and AIDS Policy Act intended to update Republic Act 8504 to incorporate lessons from the current HIV response by introducing “newer evidence-based, human rights-informed, and gender transformative strategies to prevent and treat the epidemic.”

The Philippine HIV and AIDS Policy Act was ratified by both the Senate and the House before Congress went on recess on October 10, 2018. It was then transmitted to Pres. Rodrigo Duterte on November 26, 2018

On December 20, 2018, Duterte signed the new law; although it was only on January 9, 2019 when it was made available to the public.

Some of the new law’s eminent features include:

  • Minors aged 15 to under 18 may now voluntarily get tested for HIV, as stated in Article IV, Section 29 (versus the need for approval of their parents or guardians, as previously required under Republic Act 8504).
  • Mandate for the Department of Health (DOH) to establish a program that would provide free and accessible anti-retroviral treatment and medication for opportunistic infections to people living with HIV who would enroll in the program.
  • Mandate for the Philippine Health Insurance Corporation to develop a benefit package for PLHIVs to include coverage for inpatient and outpatient medical and diagnostic services, including medication and treatment. It is now prohibited by law to deny PLHIVs private health and life insurance coverage and claims.
  • Development of basic and age-appropriate instruction on the causes, modes of transmission and prevention of HIV, AIDS and other sexually-transmitted infections in public and private schools, including alternative and indigenous learning systems.
  • Mandate for the Department of Education to conduct awareness-building seminars in coordination with parent-teacher organizations to provide parents and guardians with a “gender-responsive and age-sensitive HIV and AIDS education.”
  • Provision of education on HIV and AIDS shall to all public and private employers and employees, members of the military and police, overseas Filipino workers, communities and key populations at higher risk for infection.
  • Jail term of six months to two years and/or a fine of not less than ₱50,000 on anyone who discloses the information that a person has AIDS, undergone an HIV-related test, has HIV or HIV-related illnesses or has been exposed to HIV, without their written consent.
  • Prohibition of disclosure of the name, picture or any information that would identify people living with HIV and AIDS or any confidential HIV and AIDS information on media without their written consent. The mass dissemination of these confidential information would be punished with imprisonment for two years and one day to five years, and/or a fine of ₱150,000 to ₱350,000.
  • Jail term of six months to five years and/or a fine of ₱50,000 to ₱500,000 for those discriminating against PLHIVs; and may have their business permit, business license or accreditation or professional license suspended or revoked.
READ:  AIDS Law no longer responds to current situation - PLCPD

Incidentally, the Philippines has the fastest growing HIV epidemic in the Asia-Pacific, with infections jumping by 140% from 2010 to 2016. The country currently records 32 new HIV cases every day, though responses to this have varied – e.g. the DOH has been criticized for complaining about budget cuts, and yet spending money on a beauty pageant; while there are NGOs criticized for putting profit before service in HIV-related efforts.

Following the signing of the Philippine HIV and AIDS Act by Duterte, Secretary of Health Francisco T. Duque III released a statement via the media relations unit of the DOH stating that “the signing of the Philippine HIV and AIDS Act is a huge step forward in responding to the growing HIV epidemic in the Philippines” because now, “mabibigyan na natin ng tamang suporta ang mga Pilipinong may HIV-AIDS (we can give proper support to PLHIVs).”

But the sentiment may be put in bad light because of the ongoing ARV shortage affecting the HIV community, wth a growing number of Filipino PLHIVs now lamenting: 1. not receiving regular supplies of ARVs (some allegedly getting meds only for a week or even three days, instead of the usual three months’ supply); 2. being shifted to another ARV because their usual/regular medicines are not available due to procurement issues by the DOH; or 3. being made to use expired medicines because there are no other available medicines for them.

With the new law, the next step is now to develop and then properly execute an Implementing Rules and Regulations to guide executive officials in implementing the law, as well as the public in how to comply with the law.

READ:  13 countries from APAC plan scale-up of PrEP and HIV self-testing; challenges remain

UPDATED ON JANUARY 9: An earlier version of this article stated that the the HIV and AIDS Policy Act lapsed into law, 30 days since it was transmitted by Congress to Malacañang, where Pres. Rodrigo Duterte failed to sign it. Laws transmitted to Malacañang which are not acted on for 30 days lapse into law; and initially, it was thought that Duterte neither signed nor vetoed the HIV and AIDS Policy Act, therefore it lapsed to becomes the country’s new HIV-related law. However, the copy of the RA 11166 released by Malacañan Palace shows that the law was actually signed by the President on December 20, 2018.

Continue Reading

POZ

Community-based HIV testing effective in reaching undiagnosed populations – study

New strategies and models of HIV testing are urgently needed to reach undiagnosed populations and help them enroll in antiretroviral therapy. And here, community-based HIV screening is an effective approach.

Published

on

It is estimated that one in three people living with HIV remain undiagnosed, so that new strategies and models of HIV testing are urgently needed to reach undiagnosed populations and help them enroll in antiretroviral therapy (ART).

This was stressed by an evaluation study published in PLOS ONE, which noted that HIV testing by lay providers can serve as a critical addition to efforts to achieve the United Nations’ 90-90-90 global HIV targets by 2020 and help to cover the “last mile” of HIV services to at-risk populations.

The evaluation study was done in Vietnam by PATH, in partnership with the Vietnam Ministry of Health, the United States Agency for International Development (USAID), and the Center for Creative Initiatives in Health and Population in Hanoi. It found that community-based HIV testing is “an effective approach to reach people at risk of HIV who have never been tested or test infrequently.”

Key at-risk populations include people who inject drugs, men who have sex with men, female sex workers, and first-time HIV testers.

A cross-sectional survey of 1,230 individuals tested by lay providers found that 74% of clients belonged to at-risk populations, 67% were first-time HIV testers, and 85% preferred lay provider testing to facility-based testing. Also, lay provider testing yielded a higher HIV positivity rate compared to facility-based testing and resulted in a high ART initiation rate of 91%.

According to Dr. Kimberly Green, PATH HIV & TB director, “innovation in HIV testing is absolutely critical to meet (the 90-90-90) ambitious targets, and community-based HIV testing offers a promising solution to connect undiagnosed people with the services they need.”

READ:  Sounding the warning bell amid optimism at global HIV response

Lay providers participating in this study belonged to community-based organizations led by at-risk populations in urban areas and to village health worker networks in rural mountainous areas. Providers used a single rapid diagnostic test in clients’ homes, at the offices of community-based organizations, or at any private place preferred by the client. This approach helped to overcome barriers that had prevented key populations from seeking facility-based testing services, such as a perceived lack of confidentiality, fear of stigma and discrimination, inconvenient service opening times and distance, and long waiting times for test results.

Clients who had an HIV-reactive test were referred to the nearest health facility for HIV confirmatory testing, and those who received a confirmed HIV-positive result were referred to a public or private clinic for enrollment in ART. Clients with non-reactive test results received counseling to re-test after three or six months and were referred to a local health facility for HIV prevention services.

The study stresses the effectiveness of HIV testing administered by non-health care workers representing key populations and frontline village health volunteers. The results also support findings from community-based HIV testing approaches in other regions, including sub-Saharan Africa, that have demonstrated comparatively high rates of HIV testing uptake, high HIV positivity yields, and high success rates in linking people to care.

Continue Reading

Editor's Picks

PSA tackles in Filipino Sign Language what happens after rapid HIV test

What happens after you get tested for HIV? Particularly to “help simplify the HIV discussion for the Deaf community in the Philippines,” a public service announcement was released on getting tested for HIV in the Philippines, and what happens after one gets tested.

Published

on

One of the biggest confusions re HIV testing in the Philippines is answering the question on “what happens after one gets tested for HIV,” said Disney Aguila, board member of Bahaghari Center for SOGIE Research, Education and Advocacy, Inc. (Bahaghari Center) and concurrent president of Pinoy Deaf Rainbow (PDR).

The confusion is not helped by numerous factors – e.g.: various testing facilities are, in a way, “autonomous”, so there are varying practices; and information about post-testing remains limited.

No matter the reason/s for the confusion, “the effect is the same: it discourages many people from getting HIV testing and/or screening,” Aguila said.

To demystify particularly rapid HIV screening to “help simplify the HIV discussion for the Deaf community in the Philippines,” a public service announcement (PSA) was released on getting tested for HIV in the Philippines, and what happens after one gets tested.

The PSA is the third in a series of PSAs produced as part of a Bahaghari Center project backed by a collaboration between Youth LEAD and Y-PEER (Asia Pacific Center), which eyed to address Sexual Reproductive Health and Rights (SRHR) needs of Young Key Populations (YKPs) in Asia and the Pacific.

PSA on HIV basics released in Filipino Sign Language

Particularly pertaining rapid HIV test, “we want to educate particularly Deaf Filipinos about post-testing – that, if you are non-reactive, there are steps you can do to stay non-reactive; and if you’re positive, help is available to help you access treatment, care and support (including getting antiretroviral medicines) so you can live a long, healthy life.”

READ:  @Mike_Fozz: ‘Having HIV isn’t the end; fight on’

PSA on getting tested for HIV released in Filipino Sign Language

Aguila stressed that knowing one’s HIV status is important to protect oneself and others around him/her.

If one is HIV-positive, then he/she can start taking antiretroviral medicine (ARV) that will prevent the HIV (virus) from replicating and thereby help him/her stay healthy and live longer/normal lives.

And if one is HIV-negative, then he/she can take steps to stay negative (for example, by practicing safer sexual practices).

“It starts with getting oneself tested,” Aguila said, “which is why we encourage people to get tested.”

Most hospitals and clinics can give HIV testing.

Social hygiene clinics (SHC) located in select barangays can also give HIV testing and/or HIV screening.

Various non-government organizations also offer HIV testing and/or screening.

There are also people who are certified to give rapid HIV test.

A series of community-based HIV testing trainings are given to select members of the Deaf community in Metro Manila/Luzon, Visayas and Mindanao is to “empower members of the Deaf community to be more proactive in dealing with HIV by allowing the Deaf to help the Deaf.” These trainings are provided by The Red Ribbon Project, Inc.

Other supporters of the project include: Outrage Magazine, Fringe Publishing, Pinoy Deaf Rainbow, TransDeaf Philippines, Deaf Dykes United and Pinoy Deaf Queer.

Continue Reading

Editor's Picks

PSA on getting tested for HIV released in Filipino Sign Language

To demystify particularly rapid HIV testing/screening to “help simplify the HIV discussion for the Deaf community in the Philippines,” a public service announcement (PSA) was released on the getting tested for HIV in the Philippines.

Published

on

Getting tested for HIV is – as it is – already challenging for Hearing people, but “it can be argued that this is doubly difficult for Deaf people,” said Disney Aguila, board member of Bahaghari Center for SOGIE Research, Education and Advocacy, Inc. (Bahaghari Center) and concurrent president of Pinoy Deaf Rainbow (PDR). This is because “aside from dealing with the ‘usual’ issues related to getting tested for HIV that are encountered by Hearing people (including dealing with stigma and discrimination), we also have to contend with language barrier.”

Eyeing to demystify particularly rapid HIV testing/screening to “help simplify the HIV discussion for the Deaf community in the Philippines,” a public service announcement (PSA) was released on the getting tested for HIV in the Philippines.

The PSA is actually one in three PSAs produced as part of a Bahaghari Center project backed by a collaboration between Youth LEAD and Y-PEER (Asia Pacific Center), which eyed to address Sexual Reproductive Health and Rights (SRHR) needs of Young Key Populations (YKPs) in Asia and the Pacific.

PSA on HIV basics released in Filipino Sign Language

Particularly pertaining rapid HIV test, “we want to educate people that all it takes is a prick, and a person can already find out his/her HIV status… in less than 20 minutes,” Aguila said.

Knowing one’s HIV status is important, Aguila added, as a means to: protect oneself and others around him/her.

If one is HIV-positive, then he/she can start taking antiretroviral medicine (ARV) that will prevent the HIV (virus) from replicating and thereby help him/her stay healthy and live longer/normal lives.

READ:  27 Filipinos now get infected with HIV per day

And if one is HIV-negative, then he/she can take steps to stay negative (for example, by practicing safer sexual practices).

“But it all starts with getting oneself tested,” Aguila said, “which is why we encourage people to get tested.”

If these are more accessible, most hospitals and clinics can give HIV testing.

Social hygiene clinics (SHC) located in select barangays can also give HIV testing and/or HIV screening.

Various non-government organizations also offer HIV testing and/or screening.

There are also people who are certified to give rapid HIV test.

A series of community-based HIV testing trainings are given to select members of the Deaf community in Metro Manila/Luzon, Visayas and Mindanao is to “empower members of the Deaf community to be more proactive in dealing with HIV by allowing the Deaf to help the Deaf.” These trainings are provided by The Red Ribbon Project, Inc.

Other supporters of the project include: Outrage Magazine, Fringe Publishing, Pinoy Deaf Rainbow, TransDeaf Philippines, Deaf Dykes United and Pinoy Deaf Queer.

Continue Reading
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

Facebook

Most Popular